You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

1614 Results
Document
Aug 2023
Document
Sep 2023
Document
Sep 2023
Document
Dec 2023
Document
Dec 2023
Document
Dec 2023
Statistical Reports
Jan 2024
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    dexamethasone
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
carfilzomib (Unfunded),
dexamethasone,
selinexor (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Mar 2024
Document
Jan 2024
Guidelines and Advice
Status: Current
Version: 1.0
Jan 2024
Document
Feb 2024
Document
Mar 2024

Pages